Practicing medicine, fiduciary trust privacy, and public moral interloping after CruzanRIE, M. A.The Journal of medicine and philosophy. 1992, Vol 17, Num 6, pp 647-664, issn 0360-5310Article

A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy : a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care settingVAN DE KERKHOF, P. C. M; VAN DER VALK, P. G. M; LIJNEN, R. L. P et al.British journal of dermatology (1951). 2006, Vol 155, Num 4, pp 800-807, issn 0007-0963, 8 p.Article

No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasisBRANDS, S; BRAKMAN, M; BOS, J. D et al.Journal of the American Academy of Dermatology. 1999, Vol 41, Num 6, pp 991-995, issn 0190-9622Article

Low-dose narrow-band UVB phototherapy combined with topical therapy is effective in Psoriasis and does not inhibit systemic T-cell activationDE RIE, M. A; OUT, T. A; BOS, J. D et al.Dermatology (Basel). 1998, Vol 196, Num 4, pp 412-417, issn 1018-8665Conference Paper

Cyclosporin A levels in suction-blister fluid of patients with psoriasis treated systemicallyMEINARDI, M. M. H. M; VAN EENDINBURG, J. P; OOSTING, J et al.British journal of dermatology (1951). 1990, Vol 122, Num 5, pp 671-676, issn 0007-0963, 6 p.Article

Oral cyclosporin A in the treatment of psoriasis : an overview of studies performed in the NetherlandsMEINARDI, M. M. H. M; DE RIE, M. A; BOS, J. D et al.British journal of dermatology. Supplement. 1990, Vol 122, Num 36, pp 27-31, issn 0366-077X, 5 p.Conference Paper

Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single-centre database analysisMENTING, S. P; SITARAM, A. S; BONNERJEE-VAN DER STOK, H. M et al.British journal of dermatology (1951). 2014, Vol 171, Num 4, pp 875-883, issn 0007-0963, 9 p.Article

Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasisDRIESSEN, R. J. B; DE JONG, E. M. G. J; DE RIE, M. A et al.British journal of dermatology (1951). 2008, Vol 159, Num 3, pp 760-761, issn 0007-0963, 2 p.Article

Patients with moderate-to-severe plaque psoriasis preferred oral therapies to phototherapies : A preference assessment based on clinical scenarios with trade-off questionsOPMEER, B. C; HEYDENDAEL, V. M. R; DEBORGIE, C. A. J. M et al.Journal of clinical epidemiology. 2007, Vol 60, Num 7, pp 696-703, issn 0895-4356, 8 p.Article

Early effects of tumour necrosis factor α blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritisGOEDKOOP, A. Y; KRAAN, M. C; TEUNISSEN, M. B. M et al.Annals of the rheumatic diseases. 2004, Vol 63, Num 7, pp 769-773, issn 0003-4967, 5 p.Article

Pharmacoeconomic evaluation of Calcipotriol (daivonex®/dovonex®) and UVB phototherapy in the treatment of psoriasis : A Markov model for The NetherlandsDE RIE, M. A; DE HOOP, D; JÖNSSON, L et al.Dermatology (Basel). 2001, Vol 202, Num 1, pp 38-43, issn 1018-8665Article

Lack of efficacy of topical cyclosporin A in atopic dermatitis and allergic contact dermatitisDE RIE, M. A; MEINARDI, M. M. H. M; BOS, J. D et al.Acta dermato-venereologica. 1991, Vol 71, Num 5, pp 452-454, issn 0001-5555Article

Inhibition, by vinca alkaloids and colchicine, of antigenic modulation induced by anti-CD19 monoclonal antibodiesDE RIE, M. A; ZEIJLEMAKER, W. P; VON DEM BORNE, A. E. G. K et al.Leukemia research. 1988, Vol 12, Num 2, pp 135-141, issn 0145-2126Article

Satisfaction with treatment among patients with psoriasis: a web-based survey studyVAN CRANENBURGH, O. D; DE KORTE, J; SPRANGERS, M. A. G et al.British journal of dermatology (1951). 2013, Vol 169, Num 2, pp 398-405, issn 0007-0963, 8 p.Article

Survey among patients with basal cell carcinoma in The NetherlandsGERRITSEN, M. J. P; DE RIE, M. A; BELJAARDS, R. C et al.Journal of dermatological treatment. 2009, Vol 20, Num 4, pp 213-218, issn 0954-6634, 6 p.Article

Initial experience with routine administration of etanercept in psoriasisDE GROOT, M; APPELMAN, M; SPULS, P. I et al.British journal of dermatology (1951). 2006, Vol 155, Num 4, pp 808-814, issn 0007-0963, 7 p.Article

A new psoralen-containing gel for topical PUVA therapy : development, and treatment results in patients with palmoplantar and plaque-type psoriasis, and hyperkeratotic eczemaDE RIE, M. A; VAN EENDENBURG, J. P; VERSNICK, A. C et al.British journal of dermatology (1951). 1995, Vol 132, Num 6, pp 964-969, issn 0007-0963Conference Paper

Quantitation of soluble CD27, a T-cell activation antigen, and soluble interleukin-2 receptor in serum from patients with psoriasisDE RIE, M. A; HAMERLINCK, F; HINTZEN, R. Q et al.Archives of dermatological research (Print). 1991, Vol 283, Num 8, pp 533-534, issn 0340-3696Article

Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation modelVUIST, W. M. J; BUITENEN, F. V; DE RIE, M. A et al.Cancer research (Baltimore). 1989, Vol 49, Num 14, pp 3783-3788, issn 0008-5472Article

Evaluation of a method of production and purification of monoclonal antibodies for clinical applicationsDE RIE, M. A; ZEIJLEMAKER, W. P; VON DEM BORNE, A. E. G. K et al.Journal of immunological methods. 1987, Vol 102, Num 2, pp 187-193, issn 0022-1759Article

Q-switched laser depigmentation in vitiligo, most effective in active diseaseKOMEN, L; ZWERTBROEK, L; BURGER, S. J et al.British journal of dermatology (1951). 2013, Vol 169, Num 6, pp 1246-1251, issn 0007-0963, 6 p.Article

Expression of the T-cell activation antigens CD27 and CD28 in normal and psoriatic skinDE RIE, M. A; CAIRO, I; VAN LIER, R. A. W et al.Clinical and experimental dermatology (Print). 1996, Vol 21, Num 2, pp 104-111, issn 0307-6938Article

Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis : A comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1DE RIE, M. A; ZONNEVELD, I. M; WITKAMP, L et al.Acta dermato-venereologica. 1996, Vol 76, Num 5, pp 357-360, issn 0001-5555Article

Cyclosporin A: a new therapeutic modality in the treatment of severe atopic dermatitisMEINARDI, M. M. H. M; ZONNEVELD, I. M; DE RIE, M. A et al.Journal of dermatological treatment. 1994, Vol 5, pp S5-S7, issn 0954-6634, SUP1Article

Responsiveness of moderate psoriatic skin lesions to 1, 2 or 3 mg/kg/day ciclosporin A: a multicenter studyTEGELBERG-STASSEN, M. J. A. M; LAMMERS, A. M; ROMPELMAN-SCHIERE, S et al.EJD. European journal of dermatology. 1992, Vol 2, Num 3, pp 147-150Article